Abstract
Ever since the development of the first antibiotic compound with anticancer potential, researchers focused on isolation and characterization of prospective microbial natural products with potential anti-infective and anticancer activities. The present work describes the production of bioactive metabolites by heterotrophic bacteria associated with intertidal seaweeds with potential anti-infective and anticancer activities. The bacteria were isolated in a culture-dependent method and were identified as Shewanella algae MTCC 12715 (KX272635) and Bacillus amyloliquefaciens MTCC 12716 (KX272634) based on combined phenotypic and genotypic methods. Further, the bacteria were screened for their ability to inhibit drug-resistant infectious pathogens and prevent cell proliferation of human liver carcinoma (HepG2) and breast cancer (MCF7) cell lines, without affecting the normal cells. Significant anti-infective activity was observed with bacterial cells and their organic extracts against broad-spectrum multidrug-resistant pathogens, such as vancomycin-resistant Enterococcus faecalis, methicillin-resistant Staphylococcus aureus, Klebsiella pneumonia and Pseudomonas aeruginosa with minimum inhibitory concentration ≤ 3.0 µg mL−1 as compared to the antibiotic agents’ chloramphenicol and ampicillin, which were active at ≥ 6.25 mg mL−1. The extracts also exhibited anticancer activity in a dose-responsive pattern against HepG2 (with IC50, half maximal inhibitory concentration ~ 78–83 µg mL−1) and MCF7 (IC50 ~ 45–48 µg mL−1) on tetrazolium bromide screening assay with lesser cytotoxic effects on normal fibroblast (L929) cell lines (IC50 > 100 µg mL−1). The results revealed that seaweed-associated heterotrophic bacteria could occupy a predominant role for a paradigm shift towards the development of prospective anti-infective and anticancer agents.
This is a preview of subscription content, log in via an institution to check access.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Chakrabarty AM (2003) Microorganisms and cancer: quest for a therapy. J Bacteriol 185(9):2683–2686
Cragg GM, Newman DJ (2009) Nature: a vital source of leads for anticancer drug development. Phytochem Rev 8:313–331
Gulder TA, Moore BS (2010) Salinosporamide natural products: potent 20 S proteasome inhibitors as promising cancer chemotherapeutics. Angew Chem Int Ed Engl 49(49):9346–9367
Hussein HA, Abdullah MA (2020) Anticancer compounds derived from marine diatoms. Mar Drugs 18(7):356
Imamura N, Nishijima M, Takadera T, Adachi K, Sakai M, Sano H (1997) New anticancer antibiotics pelagiomicins, produced by a new marine bacterium Pelagiobacter variabilis. J Antibiot (Tokyo) 50(1):8–12
Kizhakkekalam VK, Chakraborty K (2019) Pharmacological properties of marine macroalgae-associated heterotrophic bacteria. Arch Microbiol 201(4):505–518
Kizhakkekalam VK, Chakraborty K (2020) Marine macroalgae-associated heterotrophic Firmicutes and Gamma-proteobacteria: prospective anti-infective agents against multidrug resistant pathogens. Arch Microbiol 202(4):905–920
Kubanek J, Jensen PR, Keifer PA, Sullards MC, Collins DO, Fenical W (2003) Seaweed resistance to microbial attack: a targeted chemical defense against marine fungi. Proc Natl Acad Sci USA 100(12):6916–6921
Lamm DL, Reichert DF, Harris SC, Lucio RM (1982) Immunotherapy of murine transitional cell carcinoma. J Urol 128(5):1104–1108
Li Y, Xu Y, Liu L, Han Z, Lai PY, Guo X, Zhang X, Lin W, Qian PY (2012) Five new amicoumacins isolated from a marine-derived bacterium Bacillus subtilis. Mar Drugs 10(2):319–328
Longford SR, Tujula N, Crocetti GR, Holmes AJ, Holmström C, Kjelleberg S, Steinberg P, Taylor MW (2007) Comparisons of diversity of bacterial communities associated with three sessile marine eukaryotes. Aquat Microb Ecol 48(3):217–229
Newman DJ, Cragg GM (2014) Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Mar Drugs 12(1):255–278
Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, Capaccioli S (2009) Natural compounds for cancer treatment and prevention. Pharmacol Res 59(6):365–378
Penesyan A, Kjelleberg S, Egan S (2010) Development of novel drugs from marine surface associated microorganisms. Mar Drugs 8(3):438–459
Pham JV, Yilma MA, Feliz A, Majid MT, Maffetone N, Walker JR, Kim E, Cho HJ, Reynolds JM, Song MC, Park SR, Yoon YJ (2019) A review of the microbial production of bioactive natural products and biologics. Front Microbiol 10:1404
Price P, McMillan TJ (1990) Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 50(5):1392–1396
Thilakan B, Chakraborty K, Chakraborty RD (2016) Antimicrobial properties of cultivable bacteria associated with seaweeds in Gulf of Mannar of South East Coast of India. Can J Microbiol 62(8):668–681
Villarreal-Gómez L, Soria-Mercado IE, Guerra-Rivas G, Ayala-Sánchez N (2010) Antibacterial and anticancer activity of seaweeds and bacteria associated with their surface. Rev Biol Mar Oceanogr 45(2):267–275
Wei Y, Pattingre S, Sinha S, Bassik M, Levine B (2008) JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 30(6):678–688
Zimmermann KC, Bonzon C, Green DR (2001) The machinery of programmed cell death. Pharmacol Ther 92(1):57–70
Acknowledgements
This work was funded by the Kerala State Council for Science, Technology and Environment (Grant no. 040/FSHP-LSS/2014/KSCSTE) and Indian Council of Agricultural Research (ICAR) under the project titled as “Development of Bioactive Pharmacophores from Marine Organisms” (Grant number MBT/HLT/SUB23). The authors thank the Director, Central Marine Fisheries Research Institute and Dean, Faculty of Marine Sciences, Lakeside Campus, Cochin University of Science and Technology for support. Thanks are due to the Head, Marine Biotechnology Division, Central Marine Fisheries Research Institute for facilitating the research activities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No potential conflict of interest was reported by the authors.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Communicated by Erko Stackebrandt.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kizhakkekalam, V.K., Chakraborty, K. Seaweed-associated heterotrophic bacteria: new paradigm of prospective anti-infective and anticancer agents. Arch Microbiol 203, 1241–1250 (2021). https://doi.org/10.1007/s00203-020-02106-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-020-02106-4